Pacific Biosciences of California Inc (NAS:PACB)
$ 1.86 0.06 (3.33%) Market Cap: 506.90 Mil Enterprise Value: 908.43 Mil PE Ratio: 0 PB Ratio: 1.03 GF Score: 62/100

Pacific Biosciences of California Inc at UBS Genomics 2.0 and MedTech Innovations Summit Transcript

Aug 11, 2021 / 08:00PM GMT
Release Date Price: $29.86 (-2.74%)
Daniel Brennan

Hi. All right. So here on our next panel on NGS technology and how it applies to both research and clinical. We're excited to have Christian Henry, President and CEO of PacBio, who has Zoomed in. And then Sean George from Invitae is also here in person. So hi, guys.

Christian O. Henry
Pacific Biosciences of California, Inc. - President, CEO & Director

Hi.

Questions & Answers

Daniel Brennan

So maybe to start things off, you have a perspective on both sides, and PacBio and Invitae has -- have talked about the partnership that they have there. But what is the basis for the partnership between Invitae and PacBio? And maybe starting with Christian, could you provide your thoughts there on the partnership?

Christian O. Henry
Pacific Biosciences of California, Inc. - President, CEO & Director

Yes. I can. First of all, thanks for this invitation. Sorry, I couldn't be there live. Looks nice. But the -- Sean -- when I joined the company, the first -- one of

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot